Covid-19: UK approves Pfizer and BioNTech vaccine with rollout due to start next week

News

BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4714 (Published 02 December 2020) Cite this as: BMJ 2020;371:m4714

Read our latest coverage of the coronavirus outbreak

Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review
- Abstract
- Fulltext
- PDF
Vaccination against COVID-19 and societys return to normality in England: a modelling study of impacts of different types of naturally acquired and vaccine-induced immunity
- Abstract
- Fulltext
- PDF
Resurgence of SARS-CoV-2: Detection by community viral surveillance
- Abstract
- Fulltext
- PDF
Vaccination against COVID-19 and societys return to normality in England: a modelling study of impacts of different types of naturally acquired and vaccine induced immunity
- Abstract
- Fulltext
- PDF
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD protein vaccine against COVID-19 in adults: pooled analysis of two randomized, double-blind, placebo-controlled, phase 1 and 2 trials
- Abstract
- Fulltext
- PDF
Time use and social mixing during and around festive periods: Potential changes in the age distribution of COVID-19 cases from increased intergenerational interactions
- Abstract
- Fulltext
- PDF
Cultural competence in covid-19 vaccine rollout
- Abstract
- Fulltext
- PDF
Shepherding preprints through a pandemic
- Abstract
- Fulltext
- PDF
The new normal
- Abstract
- Fulltext
- PDF